In addition to planning and pre-disaster exercises essential for allocating resources and devising effective mental health interventions, this book also includes two CDs showing an international panel of experts discussing how best to plan for a bioterrorist event. Although only twelve people died after the sarin gas attack on the Tokyo subway system in 1995, more than five thousand sought medical care for the effects of possible exposure. Bioterrorism can create chaos and disruption on a national and international scale. Moreover, it is believed to incur the most devastating psychological sequelae of all disasters.
The release of nerve gas in the Tokyo subways, the spread of biological weapons, and the anthrax attack of 2001 in the United States demonstrate that not only is the threat of such menacing weapons real, but also that we must urgently prepare to deal with future acts of bioterrorism. In Biological Weapons Defense: Infectious Diseases and Counterbioterrorism, prominent experts in biodefense research-many from the US Army Medical Research Institute of Infectious Diseases-authoritatively delineate the universe of scientific, medical, and legal issues facing the biodefense research community. Regarding medical countermeasures and decontamination, the authors review the facts about both the aerosol route of infection and decontamination processes, and fully describe the pathogenesis and treatment of a variety of established pathogens (anthrax, plague, smallpox, Brucellosis, glanders, and Coxiella burnetii). They also examine how to discover the presence of these agents, or other previously unknown biological weapons, and the ongoing efforts to counter such agents, including proteomic and genomic analysis as a gateway to better diagnostics, therapeutics, vaccinations, genotyping, and forensics. Additional chapters discuss the development and use of technology to identify and characterize these infectious organisms and their emerging threats. Comprehensive and authoritative, Biological Weapons Defense: Infectious Diseases and Counterbioterrorism provides researchers, physicians, and policymakers with a sound basis for understanding not only the diseases caused by these infectious organisms, but also an appreciation of the universe of bioterrorism problems that must be mastered to develop effective countermeasures.
Biosecurity and Bioterrorism, Second Edition, takes a holistic approach to biosecurity, with coverage of pathogens, prevention, and response methodology. It addresses these hazards in the context of vulnerability assessments and the planning strategies government and industry can use to prepare for and respond to such events. The book is organized into four thematic sections: Part I provides a conceptual understanding of biowarfare, bioterrorism and the laws we have to counteract this; Part II investigates known bioagents and the threat from emerging diseases; Part III focuses on agricultural terrorism and food security; and Part IV outlines international, US, and local initiatives for biodefense and biosecurity. Case studies illustrate biodefense against both intentional terrorism and natural outbreaks. - Covers emerging threats of pandemic influenza, antibiotic resistant strains of bacterial pathogens, and severe respiratory diseases caused by novel viruses - Offers increased international coverage, including initiatives to counter biological weapons and threats, and food security - Updated throughout with latest protocols for dealing with biological threats and new case studies - Includes online instructor ancillaries - PowerPoint lecture slides, test questions, and an instructor manual, for increased classroom functionality
NOTE: NO FURTHER DISCOUNT FOR THIS PRINT PRODUCT-- OVERSTOCK SALE -- Significantly reduced list price while supplies last Addresses weaponization of biological agents. Categorizes potential agents as food, waterborne, or agricultural toxins and discusses the respective epidemiology.
Reflecting the critical threat posed by biological warfare and terrorism in a post 9-11 world, Medical Aspects of Biological Warfare (an update of Medical Aspects of Chemical and Biological Warfare published in 1997) addresses the weaponization of biological agents, categorizing potential agents as food, waterborne, or agricultural agents or toxins, and discusses their respective epidemiology. Recent advances in biomedical knowledge are presented that include descriptions of individual agents and the illnesses induced. Authors discuss biotoxins and explain methods for early identification for anthrax, plague, smallpox, alphaviruses, and staphylococcal enterotoxins. Case studies and research on successful management practices, treatments, and antidotes are also included.
In the battle against bioterrorism, one of the greatest challenges is finding the ideal balance between complacency and overreaction. The goal is to be so well prepared that we can prevent catastrophic outcomes in the event of a bioterrorist attack, while strengthening our ability to prevent and treat naturally-occurring infectious diseases.Bioterr
In 2003, the President’s budget for bioterrorism defense totalled more than $5 billion. Today, the nation’s top academic scientists are scrambling to begin work to understand Bacillus anthracis and develop new vaccines and drugs. However, just five years ago, only the US Department of Defense (DOD) seemed concerned about these “exotic” agents. In 1997, the DOD spent approximately $137 million on biodefense to protect the deployed force, while academe, industry, local governments, and most of our federal leadership was oblivious to, and in some cases doubtful of, the seriousness of the threat. The National Institutes of Health (NIH) received the largest budget increase in the organization’s history. Fortunately, during this time of national urgency, a sound base exists on which to build our defenses against this new threat. A relatively small cadre of dedicated scientists within the US Army Medical Research and Materiel Command (USAMRMC) laid this foundation over the past 20 years.
This is the second edition of this publication which focuses on the public health aspects of the possible deliberate use of biological or chemical agents. Issues discussed include: the key principles for public health planning, risk assessment, hazard identification and evaluation, risk management strategies, and response planning as part of existing national emergency plans, disease surveillance and early warning systems, the national and international legal framework, and international sources of assistance. Technical annexes cover a range of issues including chemical agents, toxins, biological agents, principles of protection, precautions against the sabotage of drinking water, food and other products, information resources and the affiliation of WHO Member States to the international treaties on biological and chemical weapons.
Author: United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies
